Spain – Pharmaceutical products – Adjudicación del Contrato Específico del Medicamento BIMEKIZUMAB, derivado del Sistema
Consorci Sanitari Integral awarded €1.9M to UCB PHARMA,S.A for Construction & Public Works in June 2026 — one of 263 awards this buyer has made, above its typical award size.
Buying agency
Consorci Sanitari IntegralWinning supplier
UCB PHARMA,S.AContract description
Spain – Pharmaceutical products – Adjudicación del Contrato Específico del Medicamento BIMEKIZUMAB, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral
Related awards · Consorci Sanitari Integral
263 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-210151-2025EMPRESAS ADJUDICADAS EN EL CONTRATO BASADO (homologadas en el acuerdo marco de referencia)€19.8M02 Apr 2025 Construction
- ocds-ted-628598-2024HORI-HORI, S.A.€10.2M17 Oct 2024 Professional Services
- ocds-ted-2205-2025VEOLIA SERVEIS CATALUNYA, S.A.U.€8.0M03 Jan 2025 Professional Services
Other wins · UCB PHARMA,S.A
36 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-189519-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€3.7M25 Mar 2025 Construction
- ocds-ted-278195-2024-1OSAKIDETZA - Servicio Vasco de Salud - Organización Central€1.9M13 May 2024 Construction
- ocds-ted-386398-2026Gestió Pius Hospital de Valls, SAM€923K05 Jun 2026 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Consorci Sanitari Integral and UCB PHARMA,S.A — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back